4893 items matching your search terms.

A phase I study of the vascular-disrupting agent BNC105P in combination with gemcitabine-carboplatin in platinum-sensitive ovarian cancer patients in first or second relapse

Rischin, D Beales, P.J. Rossi, E.C. Goh, J.C. Vaughan, M.M. Tenney, M.E. Martyn, J. Sommeijer, D.W. Iglesias, J.L. Kremmidiotis, G. Simpson, J.A. Doolin, E.E. Lavarnos, T.C. Leske, A.F. Veillard, A.S. Stockler, M. ANZGOG and HOG,

The use of 3-dimensional ultrasound of the pelvic floor to predict recurrence risk after pelvic reconstructive surgery

Rodrigo, N. Wong, V. Shek, K.L. Martin, A. Dietz, H.P.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014     DOI:10.1111/ajo.12171

The efficacy and safety outcomes of bevacizumab and systemic therapy in metastatic colorectal cancer patients with peritoneal disease in the AGITG MAX clinical trial and in non-trial patients in two cancer centres

Roohullah, A Sjoquist, K Gebski, V Ng, W Chua, W. Price, T Tebbutt, N Chantrill, L

Safety and efficacy of bevacizumab and systemic therapy in metastatic colorectal cancer patients with peritoneal disease in the Treatment of Recurrent and Advanced Colorectal Cancer (TRACC) database

Roohullah, A Wong, HL Sjoquist, KM Field, KM Tran, B Shapiro, JD McKendrick, JJ Yip, D Nott, LM Gibbs, P Chantrill, L

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

Rosmarin, D. Palles, C. Church, D. Domingo, E. Jones, A. Johnstone, E. Wang, H. Love, S. Julier, P. Scudder, C. Nicholson, G. Gonzalez-Neira, A. Martin, M. Sargent, D. Green, E. McLeod, H. Zanger, U. M. Schwab, M. Braun, M. Seymour, M. Thompson, L. Lacas, B. Boige, V. Ribelles, N. Afzal, S. Enghusen, H. Jensen, S. A. Etienne-Grimaldi, M. C. Milano, G. Wadelius, M. Glimelius, B. Garmo, H. Gusella, M. Lecomte, T. Laurent-Puig, P. Martinez-Balibrea, E. Sharma, R. Garcia-Foncillas, J. Kleibl, Z. Morel, A. Pignon, J. P. Midgley, R. Kerr, D. Tomlinson, I.
JOURNAL OF CLINICAL ONCOLOGY, 2014     DOI:10.1200/JCO.2013.51.185

Early predictors of improved long-term outcomes in first-line antiangiogenics plus chemotherapy in metastatic colorectal cancer: analysis of individual patient data from the ARCAD database

Saad, ED Coart, E Sommeijer, DW Shi, Q Zalcberg, JR Burzykowski, T Meyers, JP Hoff, PM Hecht, R Hurwitz, H Tol, J Tebbutt, NC Fuchs, CS Diaz-Robio, E Souglakos, J Falcone, A Kabbinavar, FF Sargent, DJ De Gramont, A Buyse, ME for the ARCAD Group,

Manipulation and assessment of gut microbiome for metabolic studies

Satoor, S.N. Patil, D.P. Kristensen, H.D. Joglekar, M.V. Shouche, Y. Hardikar, A.A.
, 2014     DOI:10.1007/978-1-4939-1215-5_26

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine ±oxaliplatin in locally advanced rectal cancer: interim analysis for disease-free survival of PETACC 6

Schmoll, H. Haustermanns, K. Price, T.J. Nordlinger, B. Hofheinz, R. Daisne, J. Janssens, J.F. Brenner, B. Schmidt, P. Reinel, H. Hollerbach, S. Caca, K. Fauth, F.W. Hannig, C.V. Zalcberg, J. Tebbutt, N.C. Mauer, M. Messina, C.G. Lutz, M. Van Cutsem, E.

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: disease-free survival results at interim analysis

Schmoll, H.J. Haustermans, K. Price, T.J. Nordlinger, B. Hofheinz, R. Daisne, J.F. Janssens, J. Brenner, B. Schmidt, P. Reinel, H. Hollerbach, S. Caca, K. Fauth, F.W.B. Hannig, C. Zalcberg, J.R. Tebbutt, N.C. Mauer, M.E. Messina, C.G.M. Lutz, M.P. Van Cutsem, E.

How should we measure the impact of chronic pain? Limitations of utility measurement using the EQ-5D and SF-6D

Schofield, D.
PAIN, 2014     DOI:10.1016/j.pain.2014.07.020

The impact of diabetes on the labour force participation and income poverty of workers aged 45–64 years in Australia

Schofield, D. Cunich, M. Shrestha, R. Callander, E. Passey, M. E. Kelly, S. Tanton, R. Veerman, L.
PLOS ONE, 2014     DOI:10.1371/journal.pone.008936

The impact of chronic conditions of care recipients on the labour force participation of informal carers in Australia: which conditions are associated with higher rates of non-participation in the labour force?

Schofield, D. Cunich, M. Shrestha, R. Passey, M. Kelly, S. Tanton, R. Veerman, L.
BMC PUBLIC HEALTH, 2014     DOI:10.1186/1471-2458-14-561

An evaluation of the quality of evidence underpinning diabetes management models: a review of the literature

Schofield, D. Cunich, M. M. Naccarella, L.
AUSTRALIAN HEALTH REVIEW, 2014     DOI:10.1071/AH14018

The economic impact of diabetes through lost labour force participation on individuals and government: evidence from a microsimulation model

Schofield, D. Cunich, M.M. Shrestha, R.N. Passey, M.E. Veerman, L. Callander, E.J. Keely, S.J. Tanton, R.
BMC PUBLIC HEALTH, 2014     DOI:10.1186/1471-2458-14-220

An invited commentary on Torrance et al. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?

Schofield, D.J.
PAIN, 2014     DOI:10.1016/j.pain.2014.07.020